The sales of syringes and needles in the Gulf Cooperation Council (GCC) region are expected to witness steady growth, with a projected compound annual growth rate (CAGR) of 5.40% through 2034. Market forecasts indicate that the demand for syringes and needles in GCC will reach USD 688.5 million in 2024, with sales expected to surge to USD 1,164.9 million by 2034.
This growth is driven by increasing healthcare investments, rising demand for vaccinations, and the expansion of medical infrastructure across the GCC countries. The growing prevalence of chronic diseases, such as diabetes, has also significantly contributed to the heightened need for syringes and needles, particularly for insulin administration and other injectable treatments.
Government initiatives aimed at improving healthcare accessibility and strengthening immunization programs are further propelling market expansion. The focus on patient safety and infection control is also leading to increased adoption of disposable and safety-engineered syringes, ensuring compliance with stringent healthcare regulations.
As the healthcare sector in the GCC continues to advance, the demand for high-quality, safe, and efficient syringes and needles is expected to remain strong. With ongoing medical developments and increased awareness about infection prevention, the market is well-positioned for sustained growth in the coming decade.
Request a Sample Copy Now : https://www.futuremarketinsights.com/report-sample#5245502d47432d31383734
Key Takeaways:
- The GCC syringes and needles market is projected to grow from USD 688.5 million in 2024 to USD 1,164.9 million by 2034, at a CAGR of 5.40%.
- Increasing healthcare investments and expanding medical infrastructure are driving market growth.
- Rising cases of chronic diseases, such as diabetes, are boosting demand for syringes and needles.
- Government-led immunization programs and safety regulations are accelerating product adoption.
- The focus on patient safety and infection prevention is encouraging the shift toward disposable and safety-engineered syringes.
Key Drivers of Market Growth
- Increasing Healthcare Needs: The rising demand for healthcare services, driven by factors such as population growth and an increasing prevalence of chronic diseases, is propelling the need for syringes and needles. These devices are essential for various medical procedures, including vaccinations and insulin delivery.
- Adoption of Telemedicine: The proliferation of telemedicine platforms and remote healthcare delivery models has increased the demand for syringes and needles. As patients engage in self-administration of medications or receive injections from visiting healthcare professionals, there is a growing need for user-friendly syringes designed for home use.
- Technological Innovations: Manufacturers are innovating to create syringes and needles with enhanced features, such as touchless operation and improved disinfection protocols. These advancements cater to the evolving needs of healthcare professionals in a post-pandemic environment.
Market Trends
- Focus on Preventive Healthcare: There is a growing emphasis on preventive healthcare measures, which includes vaccination campaigns and regular health screenings. This trend is driving the demand for syringes and needles as they are vital tools in administering vaccines and other injectable medications.
- Regulatory Support: Governments in the GCC region are increasingly supporting initiatives that promote safe and effective medical practices, including the use of single-use syringes to prevent infections. This regulatory backing is expected to further boost market growth.
Challenges
- Cost Pressures: The syringes and needles market faces challenges related to high fixed costs and low profit margins, which can impact manufacturers’ ability to invest in new technologies and product development.
- Market Competition: The market is characterized by intense competition among established players, which can lead to price wars and affect profitability.
Key Players in the Syringe and Needle Industry in GCC
- Becton, Dickinson and Company (BD)
- Terumo Corporation
- Smiths Medical
- Nipro Corporation
- B. Braun Melsungen AG
- Cardinal Health, Inc.
- Gerresheimer AG
- Hindustan Syringes & Medical Devices Ltd. (HMD)
- Medtronic plc
- Fresenius SE & Co. KGaA
Key Segments
By Product:
- Oral
- Hypodermic
- Standard
- Special Purpose
- Insulin
- Tuberculin
- Other Special Purpose
- Angiographic
By Usability:
- Disposable
- Reusable
By Material:
- Glass
- Polymer
By End User:
- Hospital
- Blood Collection Center
- Diabetic Care Center
- Veterinary Care Center
- Others
By Country:
- Kingdom of Saudi Arabia (KSA)
- United Arab Emirates (UAE)
- Qatar
- Bahrain
- Oman
- Kuwait
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube